Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering
Each Unit will be comprised of one common share of the Company (a 'Common Share') and one common share purchase warrant of the Company (a 'Warrant'). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price and term in the context of the market.
Innocan has applied to list its Common Shares and Warrants on the Nasdaq Capital Market under the symbols 'INNP' and 'INNPW', respectively.
ThinkEquity is acting as sole book-running manager for the offering.
This proposed offering will be made only by means of a prospectus. Upon availability, copies of the preliminary prospectus related to the proposed offering may be obtained from ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004. The final prospectus will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov.
A registration statement relating to this offering has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This communication to the market shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
Iris Bincovich Innocan Pharma's CEO stated: 'The entire Innocan Pharma team and I are thrilled with having taken this significant step in the process of our listing on the Nasdaq, which opens up exciting new opportunities for us on multiple levels.'
About Innocan
Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment, Innocan focuses on advanced, targeted online sales, through its BI Sky Global Ltd. subsidiary. www.innocanpharma.com
For further information, please contact:
Iris Bincovich, CEO15162104025++972-54-3012842+442037699377info@innocanpharma.com
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Disclaimer for Forward-Looking Information
This press release includes certain statements and information that may constitute 'forward-looking information' within the meaning of applicable Canadian securities laws and/or 'forward-looking statements' within the meaning of applicable United States securities laws (collectively, 'forward-looking statements'). Forward-looking statements relate to future events or future performance and reflect the Company's current estimates, predictions, expectations or beliefs regarding future events and include, without limitation, statements with respect to: statements relating to the public offering of the Company's common shares; the expected timing of the public offering; the registration and listing of the Company's common shares in the United States; the registration statement becoming effective; the SEC's review process; the sizing and pricing of the offering; the means by which the offering will be made; and the Company's business strategies. Often, but not always, forward-looking statements may be identified by the use of words such as 'expects', 'anticipates', 'plans', 'projects', 'estimates', 'assumes', 'intends', 'strategy', 'goals', 'objectives' or variations thereof or stating that certain actions, events or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved, or the negative of any of these terms and similar expressions.
Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements in this press release are based upon, without limitation, the following estimates and assumptions: the Company carrying out its public offering; the Company successfully completing the SEC review process; obtaining requisite regulatory approvals; and general business, economic and market conditions.
These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Important factors that may cause actual results to vary, include, without limitation, that the Company may not carry out its public offering or complete the SEC review process. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Readers are cautioned that reliance on such information may not be appropriate for other purposes.
The Company does not undertake to update any forward-looking statement or forward-looking information, except in accordance with applicable securities laws.
Logo – https://mma.prnewswire.com/media/2570689/Innocan_Pharma_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/innocan-pharma-announces-public-filing-of-registration-statement-for-proposed-us-public-offering-302512486.html
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
7 hours ago
- Malaysian Reserve
FI Investors Have Opportunity to Lead Fiserv, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, July 28, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fiserv, Inc. ('Fiserv' or 'the Company') (NYSE: FI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 24, 2024 and July 22, 2025, inclusive (the 'Class Period'), are encouraged to contact the firm before September 22, 2025. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Fiserv forced merchants using its Payeezy platform to migrant to the Clover program due to cost issues and other problems. The Company's Clover platform revenue growth was unsustainably boosted by these conversions. The Company lost customers to competitors due to Clover's high prices and poor customer service. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Fiserv, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: The Schall Law FirmBrian Schall, Esq., 310-301-3335info@
The Sun
10 hours ago
- The Sun
Eco-Shop reports 17% surge in core net profit for FY2025
KUALA LUMPUR: Eco-Shop Marketing Berhad, a player in Malaysia's dollar store retail sector, has released its fourth quarter financial results for the three months ended 31 May 2025 (4Q FY2025) today. On a full-year basis for the twelve months ended May 31, 2025 (FY2025), the Group achieved new record highs for both revenue and profit after tax (PAT). Revenue increased by 16% to RM2.8 billion, underpinned by the net addition of 74 new stores during the financial year. Despite higher operating costs arising from our expanded store network and the implementation of minimum wage policies, core PAT (adjusted for one-off IPO expenses of RM9.4 million) grew in line with revenue, rising 17% to RM213.7 million compared to the previous financial year. In 4Q FY2024, the Group recorded revenue of RM689.0 million, representing an 8% increase from RM640.7 million in the same quarter last year. Core PAT for the quarter stood at RM57.0 million, compared to RM63.4 million in the previous year's corresponding quarter. Together with this set of results, the Company declared an interim single-tier dividend of 1.0 sen per ordinary share or approximately RM57.5 million in respect of the financial year ending May 31, 2025, to be paid on August 26, 2025. The entitlement date for the dividend falls on August 12, 2025. CEO Jessica Ng said the company remains optimistic about its outlook despite ongoing macroeconomic uncertainties. 'Our confidence is underpinned by the continued expansion of our store network and rising consumer demand for value‑driven retail,' she said. Ng noted that Malaysia's value retail segment is still 'significantly underpenetrated' compared to mature markets like Japan, Canada and the United States, presenting strong long‑term growth potential. 'As consumer preferences shift toward affordability and convenience, Eco-Shop is well‑positioned to scale further and increase its relevance nationwide,' she added. On challenges, Ng acknowledged rising cost pressures from higher electricity tariffs, the expanded Sales and Services Tax and EPF contributions for foreign workers. 'We are strengthening our resilience through supply chain efficiencies, strategic pricing, product enhancements and close collaboration with suppliers,' she said. She also addressed softer same-store sales growth following the mid‑April price adjustment. 'Consumers are taking time to adapt to the new pricing. In the meantime, we are rolling out targeted marketing campaigns to boost footfall,' she said. Despite the temporary dip, Ng said margins and performance are expected to remain healthy. 'Our store network expansion continues to be a key long‑term strategy for deeper market penetration. We remain focused on delivering strong, sustainable financial performance over the long term,' she said.
Malaysian Reserve
3 days ago
- Malaysian Reserve
BOARDWALKTECH ANNOUNCES CLOSING OF LIFE NON-BROKERED PRIVATE PLACEMENT
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ CUPERTINO, Calif., July 25, 2025 /CNW/ – (TSXV:BWLK) (OTCQB:BWLKF) Boardwalktech Software Corp. (the 'Company' or 'Boardwalktech') is pleased to announce it has closed, subject to the approval of the TSX Venture Exchange (the 'TSXV'), a final tranche of its non-brokered private placement. consisting of 2,793,800 units (each, a 'Unit', and collectively the 'Units') of the Company at the price of C$0.13 per Unit for gross proceeds of approximately C$363,194 (the 'LIFE Offering'). The LIFE Offering was conducted pursuant to the Listed Issuer Financing Exemption (the 'LIFE') of National Instrument 45-106 – Prospectus Exemptions ('NI 45-106'), and was previously announced on May 16, 2025, June 16, 2025 and July 21, 2025. Each Unit consists of one common share in the capital of the Company (each a 'Common Share') and one Common Share purchase warrant (each a 'Warrant'). Each Warrant entitles the holder thereof to acquire one Common Share at a price of C$0.25 per Common Share for a period of 12 months from the closing date of the Offering. Subject to compliance with applicable regulatory requirements, and in accordance with NI 45-106, the LIFE Offering was made to purchasers resident in Canada and other qualifying jurisdictions pursuant to the LIFE Part 5A of NI 45-106. The securities issued under the LIFE Offering are not subject to a hold period in accordance with applicable Canadian securities laws. Collectively, the Company closed two tranches of the LIFE Offering for a total of 5,756,492 Units issued across both tranches of the LIFE Offering, resulting in aggregate gross proceeds of approximately C$748,344, which was at the maximum level projected in the LIFE Offering Document. The Company expects to use the net proceeds of the Offering for sales and marketing expenditures, working capital requirements, and to enhance its balance sheet to drive new business. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in this news release. Such securities have not been, and will not be, registered under the U.S. Securities Act, or any state securities laws, and, accordingly, may not be offered or sold within the United States, or to or for the account or benefit of persons in the United States or 'U.S. Persons', as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements. About Boardwalktech Software Corp. Boardwalktech has developed a patented Digital Ledger Technology Platform currently used by Fortune 500 companies running mission-critical applications worldwide. Boardwalktech's digital ledger technology and its unique method of managing vast amounts of structured and unstructured data is the only platform on the market today where multiple parties can effectively work on the same data simultaneously while preserving the fidelity and provenance of the data. Boardwalktech can deliver collaborative, purpose-built enterprise information management applications on any device or user interface with full integration with enterprise systems of record in a fraction of the time it takes other non-digital ledger technology-based platforms. Boardwalktech is headquartered in Cupertino, California with offices in India and operations in North America. For more information on Boardwalktech, visit our website at Legal Disclaimer Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statement This press release contains certain 'forward-looking information' within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute 'forward-looking statements' within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking information and statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or statements can be identified by the use of forward-looking terminology such as 'plans', 'expects' or 'does not expect', 'is expected', 'budget', 'scheduled', 'estimates', 'forecasts', 'intends', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases or may contain statements that certain actions, events or results 'may', 'could', 'would', 'might' or 'will be taken', 'will continue', 'will occur' or 'will be achieved'. The forward-looking information contained herein may include, but is not limited to, information concerning the Offering and the use of any proceeds raised under the Offering. By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading 'Risk Factors' in the Company's filing statement dated February 25, 2025. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. In connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice. Legal Disclaimer Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
